![Jinghua Pharmaceutical Group Co Ltd Logo](https://ik.imagekit.io/kkbzr2uz4cp/stock/szse/002349.png?tr=w-200)
Jinghua Pharmaceutical Group Co Ltd
SZSE:002349
![Jinghua Pharmaceutical Group Co Ltd Logo](https://ik.imagekit.io/kkbzr2uz4cp/stock/szse/002349.png)
US |
![]() |
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
US |
![]() |
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
US |
![]() |
Bank of America Corp
NYSE:BAC
|
Banking
|
US |
![]() |
Mastercard Inc
NYSE:MA
|
Technology
|
US |
![]() |
Abbvie Inc
NYSE:ABBV
|
Biotechnology
|
US |
![]() |
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
US |
![]() |
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
US |
![]() |
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
US |
![]() |
Visa Inc
NYSE:V
|
Technology
|
CN |
![]() |
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
US |
![]() |
3M Co
NYSE:MMM
|
Industrial Conglomerates
|
US |
![]() |
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
US |
![]() |
Coca-Cola Co
NYSE:KO
|
Beverages
|
US |
![]() |
Realty Income Corp
NYSE:O
|
Real Estate
|
US |
![]() |
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
US |
![]() |
Walt Disney Co
NYSE:DIS
|
Media
|
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
This note will be permanently deleted.
![](https://ik.imagekit.io/kkbzr2uz4cp/stock/szse/002349.png)
Jinghua Pharmaceutical Group Co Ltd
Interest Income Expense
Jinghua Pharmaceutical Group Co Ltd
Interest Income Expense Peer Comparison
![](https://ik.imagekit.io/kkbzr2uz4cp/stock/sse/600436.png)
![](https://ik.imagekit.io/kkbzr2uz4cp/stock/sse/600276.png)
![](https://ik.imagekit.io/kkbzr2uz4cp/stock/szse/000538.png)
Competitive Interest Income Expense Analysis
Latest Figures & CAGR of Competitors
Company | Interest Income Expense | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
![]() |
Jinghua Pharmaceutical Group Co Ltd
SZSE:002349
|
Interest Income Expense
ÂĄ42.4m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
28%
|
CAGR 10-Years
N/A
|
H
|
Hansoh Pharmaceutical Group Company Ltd
HKEX:3692
|
Interest Income Expense
ÂĄ1.1B
|
CAGR 3-Years
52%
|
CAGR 5-Years
82%
|
CAGR 10-Years
N/A
|
![]() |
Zhangzhou Pientzehuang Pharmaceutical Co Ltd
SSE:600436
|
Interest Income Expense
ÂĄ134.5m
|
CAGR 3-Years
7%
|
CAGR 5-Years
4%
|
CAGR 10-Years
23%
|
![]() |
Jiangsu Hengrui Pharmaceuticals Co Ltd
SSE:600276
|
Interest Income Expense
ÂĄ429.9m
|
CAGR 3-Years
-8%
|
CAGR 5-Years
4%
|
CAGR 10-Years
30%
|
![]() |
Yunnan Baiyao Group Co Ltd
SZSE:000538
|
Interest Income Expense
ÂĄ1.1B
|
CAGR 3-Years
-16%
|
CAGR 5-Years
-11%
|
CAGR 10-Years
37%
|
S
|
Sichuan Biokin Pharmaceutical Co Ltd
SSE:688506
|
Interest Income Expense
-ÂĄ20.1m
|
CAGR 3-Years
-107%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
See Also
What is Jinghua Pharmaceutical Group Co Ltd's Interest Income Expense?
Interest Income Expense
42.4m
CNY
Based on the financial report for Mar 31, 2024, Jinghua Pharmaceutical Group Co Ltd's Interest Income Expense amounts to 42.4m CNY.
What is Jinghua Pharmaceutical Group Co Ltd's Interest Income Expense growth rate?
Interest Income Expense CAGR 5Y
28%
Over the last year, the Interest Income Expense growth was -2%.